Wangjun Liao
- Cancer Research top 0.2%
- Cancer-related molecular mechanisms research 27
- Cancer, Hypoxia, and Metabolism 18
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 27
- Colorectal Cancer Treatments and Studies 14
- Pulmonary and Respiratory Medicine top 0.5%
- Gastric Cancer Management and Outcomes 16
- Ferroptosis and cancer prognosis 13
- Molecular Biology top 1%
- RNA modifications and cancer 21
- Circular RNAs in diseases 16
- Immunology top 2%
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Wangjun Liao
217 papers receiving 8.7k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 3.3k
- Oncology 2.2k
- Pulmonary and Respiratory Medicine 2.5k
- Molecular Biology 4.7k
- Immunology 1.1k
Countries citing papers authored by Wangjun Liao
This map shows the geographic impact of Wangjun Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangjun Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangjun Liao more than expected).
Fields of papers citing papers by Wangjun Liao
This network shows the impact of papers produced by Wangjun Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangjun Liao. The network helps show where Wangjun Liao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wangjun Liao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 8 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 61 | |
| 9 | 2023 | 50 | |
| 10 | 2023 | 14 | |
| 11 | 2022 | 20 | |
| 12 | 2022 | 3 | |
| 13 | 2021 | 38 | |
| 14 | 2021 | 19 | |
| 15 | 2021 | 23 | |
| 16 | 2021 | 43 | |
| 17 | Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signaturesbreakdown → | 2019 | 697 |
| 18 | 2016 | 14 | |
| 19 | [Killing effect of Photofrin-Herceptin immunoconjugate on tumor cell lines in vitro]. | 2005 | 1 |
| 20 | Association of progesterone receptor and HER2 expressions with the survival time of patient with breast cancer. | 2003 | 1 |
About Wangjun Liao
Wangjun Liao is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Immunology, having authored 222 papers that have together received 8.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (27 papers), Cancer-related molecular mechanisms research (27 papers), RNA modifications and cancer (21 papers), Cancer, Hypoxia, and Metabolism (18 papers), Gastric Cancer Management and Outcomes (16 papers), Circular RNAs in diseases (16 papers), Colorectal Cancer Treatments and Studies (14 papers) and Ferroptosis and cancer prognosis (13 papers). The work is most often cited by research in Cancer Research (3.3k citations), Oncology (2.2k citations), Pulmonary and Respiratory Medicine (2.5k citations), Molecular Biology (4.7k citations) and Immunology (1.1k citations). Wangjun Liao has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Yulin Liao, Jianping Bin, Min Shi, Rui Zhou, Dongqiang Zeng, Na Huang, Li Sun, Jingwen Zhang, Jinjun Rao and Huiying Sun. Their work appears in journals such as Journal of Clinical Oncology, Oncotarget, Theranostics, Molecular Therapy and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.